OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multifunctional Applications of Engineered Extracellular Vesicles in the Treatment of Cancer
Fernanda G. Kugeratski, Kathleen M. McAndrews, Raghu Kalluri
Endocrinology (2021) Vol. 162, Iss. 3
Open Access | Times Cited: 25
Fernanda G. Kugeratski, Kathleen M. McAndrews, Raghu Kalluri
Endocrinology (2021) Vol. 162, Iss. 3
Open Access | Times Cited: 25
Showing 25 citing articles:
Quantitative proteomics identifies the core proteome of exosomes with syntenin-1 as the highest abundant protein and a putative universal biomarker
Fernanda G. Kugeratski, Kelly Hodge, Sérgio Lilla, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 6, pp. 631-641
Open Access | Times Cited: 352
Fernanda G. Kugeratski, Kelly Hodge, Sérgio Lilla, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 6, pp. 631-641
Open Access | Times Cited: 352
New advances in exosome-based targeted drug delivery systems
Débora Ferreira, João Nuno Moreira, L. R. Rodrigues
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103628-103628
Open Access | Times Cited: 98
Débora Ferreira, João Nuno Moreira, L. R. Rodrigues
Critical Reviews in Oncology/Hematology (2022) Vol. 172, pp. 103628-103628
Open Access | Times Cited: 98
Advances of engineered extracellular vesicles-based therapeutics strategy
Hiroaki Komuro, Shakhlo Aminova, Katherine Lauro, et al.
Science and Technology of Advanced Materials (2022) Vol. 23, Iss. 1, pp. 655-681
Open Access | Times Cited: 29
Hiroaki Komuro, Shakhlo Aminova, Katherine Lauro, et al.
Science and Technology of Advanced Materials (2022) Vol. 23, Iss. 1, pp. 655-681
Open Access | Times Cited: 29
Placenta Extracellular Vesicles: Messengers Connecting Maternal and Fetal Systems
Cheryl S. Rosenfeld
Biomolecules (2024) Vol. 14, Iss. 8, pp. 995-995
Open Access | Times Cited: 7
Cheryl S. Rosenfeld
Biomolecules (2024) Vol. 14, Iss. 8, pp. 995-995
Open Access | Times Cited: 7
Exosomes: the next frontier in vaccine development and delivery
Dan Tan, Guangyao Li, Wenyan Fu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Dan Tan, Guangyao Li, Wenyan Fu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement
Jabeen Farheen, Narayan S. Hosmane, Ruibo Zhao, et al.
Materials Today Bio (2022) Vol. 16, pp. 100450-100450
Open Access | Times Cited: 19
Jabeen Farheen, Narayan S. Hosmane, Ruibo Zhao, et al.
Materials Today Bio (2022) Vol. 16, pp. 100450-100450
Open Access | Times Cited: 19
The therapeutic effect of MSCs and their extracellular vesicles on neuroblastoma
Mohsen Karami Fath, Samaneh Mohammad Bagherzadeh Torbati, Vahid Saqagandomabadi, et al.
Progress in Biophysics and Molecular Biology (2024) Vol. 187, pp. 51-60
Closed Access | Times Cited: 4
Mohsen Karami Fath, Samaneh Mohammad Bagherzadeh Torbati, Vahid Saqagandomabadi, et al.
Progress in Biophysics and Molecular Biology (2024) Vol. 187, pp. 51-60
Closed Access | Times Cited: 4
Engineered Immunomodulatory Extracellular Vesicles from Epithelial Cells with the Capacity for Stimulation of Innate and Adaptive Immunity in Cancer and Autoimmunity
Xin Luo, Fernanda G. Kugeratski, Dara P. Dowlatshahi, et al.
ACS Nano (2025)
Closed Access
Xin Luo, Fernanda G. Kugeratski, Dara P. Dowlatshahi, et al.
ACS Nano (2025)
Closed Access
Exosome-mediated CRISPR/Cas delivery: A cutting-edge frontier in cancer gene therapy
Bhavanisha Rithiga S, Rajib Dhar, Arikketh Devi
Gene (2025), pp. 149296-149296
Closed Access
Bhavanisha Rithiga S, Rajib Dhar, Arikketh Devi
Gene (2025), pp. 149296-149296
Closed Access
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications
Xinmei Liu, Mengyu Gao, Ji Bao
Nanomaterials (2025) Vol. 15, Iss. 7, pp. 540-540
Open Access
Xinmei Liu, Mengyu Gao, Ji Bao
Nanomaterials (2025) Vol. 15, Iss. 7, pp. 540-540
Open Access
Artificial cells and Biomimicry cells: A Rising Star in the Fight Against Cancer
Renata Faria Maia, Asma Sadat Vaziri, Mohammad‐Ali Shahbazi, et al.
Materials Today Bio (2025), pp. 101723-101723
Open Access
Renata Faria Maia, Asma Sadat Vaziri, Mohammad‐Ali Shahbazi, et al.
Materials Today Bio (2025), pp. 101723-101723
Open Access
Exosomal Delivery of Interleukin‐10 Reduces Infection‐Associated Inflammation in a 3D ‐Printed Model of a Humanized Feto–Maternal Interface
Leah Saylor, Rahul Cherukuri, Ananth Kumar Kammala, et al.
The FASEB Journal (2025) Vol. 39, Iss. 10
Closed Access
Leah Saylor, Rahul Cherukuri, Ananth Kumar Kammala, et al.
The FASEB Journal (2025) Vol. 39, Iss. 10
Closed Access
Extracellular vesicles as central regulators of blood vessel function in cancer
Fernanda G. Kugeratski, Alice Santi, Sara Zanivan
Science Signaling (2022) Vol. 15, Iss. 753
Closed Access | Times Cited: 15
Fernanda G. Kugeratski, Alice Santi, Sara Zanivan
Science Signaling (2022) Vol. 15, Iss. 753
Closed Access | Times Cited: 15
Profiling mitochondrial DNA mutations in tumors and circulating extracellular vesicles of triple‐negative breast cancer patients for potential biomarker development
Kunwar Somesh Vikramdeo, Shashi Anand, Sarabjeet Kour Sudan, et al.
FASEB BioAdvances (2023) Vol. 5, Iss. 10, pp. 412-426
Open Access | Times Cited: 8
Kunwar Somesh Vikramdeo, Shashi Anand, Sarabjeet Kour Sudan, et al.
FASEB BioAdvances (2023) Vol. 5, Iss. 10, pp. 412-426
Open Access | Times Cited: 8
Recent advancements to engineer mesenchymal stem cells and their extracellular vesicles for targeting and destroying tumors
Mohsen Karami Fath, Zahra Moayedi Banan, Reza Barati, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 1-16
Closed Access | Times Cited: 7
Mohsen Karami Fath, Zahra Moayedi Banan, Reza Barati, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 1-16
Closed Access | Times Cited: 7
Exosome-loaded decellularized tissue: Opening a new window for regenerative medicine
Shima Rahmati, Mozafar Khazaei, Zahra Abpeikar, et al.
Journal of Tissue Viability (2024) Vol. 33, Iss. 2, pp. 332-344
Closed Access | Times Cited: 2
Shima Rahmati, Mozafar Khazaei, Zahra Abpeikar, et al.
Journal of Tissue Viability (2024) Vol. 33, Iss. 2, pp. 332-344
Closed Access | Times Cited: 2
From Promise to Reality: Bioengineering Strategies to Enhance the Therapeutic Potential of Extracellular Vesicles
Miguel de Almeida Fuzeta, Pedro P. Gonçalves, Ana Fernandes‐Platzgummer, et al.
Bioengineering (2022) Vol. 9, Iss. 11, pp. 675-675
Open Access | Times Cited: 10
Miguel de Almeida Fuzeta, Pedro P. Gonçalves, Ana Fernandes‐Platzgummer, et al.
Bioengineering (2022) Vol. 9, Iss. 11, pp. 675-675
Open Access | Times Cited: 10
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression
Enea Ferlizza, Donatella Romaniello, Francesco Borrelli, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2970-2970
Open Access | Times Cited: 6
Enea Ferlizza, Donatella Romaniello, Francesco Borrelli, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2970-2970
Open Access | Times Cited: 6
Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells
Débora Ferreira, Cátia Santos‐Pereira, Marta Costa, et al.
Biomaterials Advances (2023) Vol. 154, pp. 213643-213643
Open Access | Times Cited: 6
Débora Ferreira, Cátia Santos‐Pereira, Marta Costa, et al.
Biomaterials Advances (2023) Vol. 154, pp. 213643-213643
Open Access | Times Cited: 6
Exploiting Exosomes for Cancer Diagnosis and Treatment
Fernanda G. Kugeratski, Raghu Kalluri
Current cancer research (2023), pp. 43-59
Closed Access | Times Cited: 3
Fernanda G. Kugeratski, Raghu Kalluri
Current cancer research (2023), pp. 43-59
Closed Access | Times Cited: 3
Prospective applications of extracellular vesicle-based therapies in regenerative medicine: implications for the use of dental stem cell-derived extracellular vesicles
Wenhao Wang, Zinan Xu, Minyi Liu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 2
Wenhao Wang, Zinan Xu, Minyi Liu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 2
Perspectives on Vascular Regulation of Mechanisms Controlling Selective Immune Cell Function in the Tumor Immune Response
Michael Welsh
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2313-2313
Open Access | Times Cited: 4
Michael Welsh
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2313-2313
Open Access | Times Cited: 4
Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotype
Sanshiro Kobayashi, N Kondo, Takashi Tomiyama, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3651-3664
Open Access | Times Cited: 2
Sanshiro Kobayashi, N Kondo, Takashi Tomiyama, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3651-3664
Open Access | Times Cited: 2
Engineered immunomodulatory extracellular vesicles derived from epithelial cells acquire capacity for positive and negative T cell co-stimulation in cancer and autoimmunity
Fernanda G. Kugeratski, Valerie S. LeBleu, Dara P. Dowlatshahi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Fernanda G. Kugeratski, Valerie S. LeBleu, Dara P. Dowlatshahi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Extracellular vesicles as a next-generation therapeutic nanocarrier in disease treatments
Jiacheng Tan
(2024), pp. 116-116
Closed Access
Jiacheng Tan
(2024), pp. 116-116
Closed Access
